Black Diamond Therapeutics, Inc. (BDTX)

2.13 -0.12 (-5.33%) USD  |  NASDAQ  |  Mar 12, 16:00
2.125 0.00 (0.00%) After-Hours: 20:00
More

Black Diamond Therapeutics EPS Diluted (Quarterly) : -0.1493 for Sept. 30, 2025

EPS Diluted (Quarterly) Chart

View EPS Diluted (Quarterly) for BDTX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Diluted (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

EPS Diluted (Quarterly) Range, Past 5 Years

View EPS Diluted (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (Quarterly) Benchmarks

View EPS Diluted (Quarterly) Benchmarks
Start Trial
Bionano Genomics, Inc. -1.593
ACADIA Pharmaceuticals, Inc. 1.596
Alnylam Pharmaceuticals, Inc. 1.368
Savara, Inc. -0.1366
BioMarin Pharmaceutical, Inc. -0.2423

EPS Diluted (Quarterly) Related Metrics

Net Income (Quarterly) -8.498M
Total Expenses (Quarterly) 8.498M
Enterprise Value 5.524M
Earnings Yield 17.03%
Operating Earnings Yield 9.77%
Normalized Earnings Yield 17.03